Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: A role for metabolomics

Current Drug Metabolism

Volumn 10, Issue 1, 2009, Pages 41-54

  Jacobs, Doris M ^a   Gaudier, Estelle ^a   van Duynhoven, John ^a   Vaughan, Elaine E ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Colonic microbiota; Immunity; Intestine; Metabolomics; Microbial metabolites; Non digestible food ingredients; Phenolic acids; Polyphenols; Short chain fatty acids

Indexed keywords

3 (4 HYDROXYPHENYL) PROPIONIC ACID; 3 HYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,8 DIHYDROXY 6H DIBENZO[FC,D] PYRAN 6 ONE GLUCURONIDE; 3,8,9 TRIHYDROXY 6H DIBENZO[B,D]PYRAN 6 ONE; 5 (3',4',5' TRIHYDROXYPHENYL) GAMMA VALEROLACTONE; AGLYCONE; ALPHITONIN; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; EQUOL; FLAVONOID; HISTONE DEACETYLASE; HYDROXY 6H DIBENZO[FC,D] PYRAN 6 ONE GLUCURONIDE; PHENYLACETIC ACID; POLYPHENOL DERIVATIVE; PROBIOTIC AGENT; PROPIONIC ACID DERIVATIVE; QUERCETIN; SHORT CHAIN FATTY ACID; TAXIFOLIN; TRIHYDROXY 6H DIBENZO [B,D] PYRAN 6 ONE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIFIDOBACTERIUM; BIOTRANSFORMATION; COLON FLORA; COMMENSALISM; DIET SUPPLEMENTATION; ENZYME INHIBITION; FECES ANALYSIS; FERMENTATION; FOOD COMPOSITION; FOOD INTAKE; HUMAN; IMMUNITY; IMMUNOSTIMULATION; INFLAMMATION; LACTOBACILLUS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; METABOLIC REGULATION; METABOLITE; METABOLOMICS; MICROFLORA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYLOGENY; REVIEW; URINALYSIS; ANIMAL; COLON; DIGESTION; FOOD; GASTROINTESTINAL DISEASE; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROBIOLOGY; PHENOTYPE;

ANIMALS; COLON; DIGESTION; FERMENTATION; FOOD; GASTROINTESTINAL DISEASES; HUMANS; IMMUNITY; METABOLOMICS; PHENOTYPE;

EID: 62749106838     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009787048383     Document Type: Review

References (188)

1. Backhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science, 2005, 307(5717), 1915-1920.
2. Rawls, J.F.; Samuel, B.S.; Gordon, J.I. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc. Natl. Acad. Sci. USA, 2004, 101(13), 4596-4601.
3. Backhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA, 2004, 101(44), 15718-15723.
4. Hooper, L.V.; Midtvedt, T.; Gordon, J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr., 2002, 22 283-307.
5. Falk, P.G.; Hooper, L.V.; Midtvedt, T.; Gordon, J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev., 1998, 62(4), 1157-1170.
6. Mazmanian, S.K.; Kasper, D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol., 2006, 6(11), 849-858.
7. Rook, G.A.; Stanford, J.L. Give us this day our daily germs. Immunol. Today, 1998, 19(3), 113-116.
8. Rakoff-Nahoum, S.; Hao, L.; Medzhitov, R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity., 2006, 25(2), 319-329.
9. O'Hara, A.M.; Shanahan, F. The gut flora as a forgotten organ. EMBO Rep., 2006, 7(7), 688-693.
10. Clavel, T.; Haller, D. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm. Bowel. Dis., 2007, 13(9), 1153-1164.
11. Liu, C.H.; Lee, S.M.; Vanlare, J.M.; Kasper, D.L.; Mazmanian, S.K. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc. Natl. Acad. Sci. USA, 2008, 105(10), 3951-3956.
12. Peterson, D.A.; McNulty, N.P.; Guruge, J.L.; Gordon, J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host. Microbe, 2007, 2(5), 328-339.
13. Albers, R.; Antoine, J.M.; Bourdet-Sicard, R.; Calder, P.C.; Gleeson, M.; Lesourd, B.; Samartin, S.; Sanderson, I.R.; Van Loo, J.; Vas Dias, F.W.; Watzl, B. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr., 2005, 94(3), 452-481.
14. Wolowczuk, I.; Verwaerde, C.; Viltart, O.; Delanoye, A.; Delacre, M.; Pot, B.; Grangette, C. Feeding our immune system: impact on metabolism. Clin. Dev. Immunol., 2008, 2008 639803.
15. Nicholson, J.K.; Holmes, E.; Wilson, I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol., 2005, 3(5), 431-438.
16. Nicholson, J.K.; Lindon, J.C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 1999, 29(11), 1181-1189.
17. Rajilic-Stojanovic, M.; Smidt, H.; de Vos, W.M. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol., 2007, 9(9), 2125-2136.
18. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science, 2005, 308(5728), 1635-1638.
19. Lay, C.; Rigottier-Gois, L.; Holmstrom, K.; Rajilic, M.; Vaughan, E.E.; de Vos, W.M.; Collins, M.D.; Thiel, R.; Namsolleck, P.; Blaut, M.; Dore, J. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol., 2005, 71(7), 4153-4155.
20. Lepage, P.; Colombet, J.; Marteau, P.; Sime-Ngando, T.; Dore, J.; Leclerc, M. Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut, 2008, 57(3), 424-425.
21. Zoetendal, E.G.; Vaughan, E.E.; de Vos, W.M. A microbial world within us. Mol. Microbiol., 2006, 59(6), 1639-1650.
22. Boesten, R.J.; de Vos, W.M. Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J. Clin. Gastroenterol., 2008, 42(Suppl 3 Pt 2), S163-S167.
23. Macfarlane, G.T.; Steed, H.; Macfarlane, S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol., 2008, 104(2), 305-344.
24. Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr., 1995, 125(6), 1401-1412.
25. Macfarlane, G.T.; Cummings, J.H. Probiotics, infection and immunity. Curr. Opin. Infect. Dis., 2002, 15(5), 501-506.
26. FAO/WHO. Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, 2001.
27. Gill, S.R.; Pop, M.; Deboy, R.T.; Eckburg, P.B.; Turnbaugh, P.J.; Samuel, B.S.; Gordon, J.I.; Relman, D.A.; Fraser-Liggett, C.M.; Nelson, K.E. Metagenomic analysis of the human distal gut microbiome. Science, 2006, 312(5778), 1355-1359.
28. Kurokawa, K.; Itoh, T.; Kuwahara, T.; Oshima, K.; Toh, H.; Toyoda, A.; Takami, H.; Morita, H.; Sharma, V.K.; Srivastava, T.P.; Taylor, T.D.; Noguchi, H.; Mori, H.; Ogura, Y.; Ehrlich, D.S.; Itoh, K.; Takagi, T.; Sakaki, Y.; Hayashi, T.; Hattori, M. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res., 2007, 14(4), 169-181.
29. Li, M.; Wang, B.; Zhang, M.; Rantalainen, M.; Wang, S.; Zhou, H.; Zhang, Y.; Shen, J.; Pang, X.; Zhang, M.; Wei, H.; Chen, Y.; Lu, H.; Zuo, J.; Su, M.; Qiu, Y.; Jia, W.; Xiao, C.; Smith, L.M.; Yang, S.; Holmes, E.; Tang, H.; Zhao, G.; Nicholson, J.K.; Li, L.; Zhao, L. Symbiotic gut microbes modulate human metabolic phenotypes. Proc. Natl. Acad. Sci. USA, 2008, 105(6), 2117-2122.
30. Turnbaugh, P.J.; Backhed, F.; Fulton, L.; Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host. Microbe, 2008, 3(4), 213-223.
31. Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA, 2007, 104(34), 13780-13785.
32. Frank, D.N.; Pace, N.R. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol., 2008, 24(1), 4-10.
33. Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; Gloux, K.; Pelletier, E.; Frangeul, L.; Nalin, R.; Jarrin, C.; Chardon, P.; Marteau, P.; Roca, J.; Dore, J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut, 2006, 55(2), 205-211.
34. Sutherland, J.P.; McKinley, B.; Eckel, R.H. The metabolic syndrome and inflammation. Metab Syndr. Relat. Disord., 2004, 2(2), 82-104.
35. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature, 2006, 444(7122), 1022-1023.
36. Chang, J.Y.; Antonopoulos, D.A.; Kalra, A.; Tonelli, A.; Khalife, W.T.; Schmidt, T.M.; Young, V.B. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis., 2008, 197(3), 435-438.
37. Goodacre, R. Metabolomics of a superorganism. J. Nutr., 2007, 137(1 Suppl), 259S-266S.
38. Lederberg, J. Infectious history. Science, 2000, 288(5464), 287-293.
39. Jia, W.; Li, H.; Zhao, L.; Nicholson, J.K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov., 2008, 7(2), 123-129.
40. de Graaf, A.A.; Venema, K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv. Microb. Physiol., 2008, 53 73-168.
41. Barcenilla, A.; Pryde, S.E.; Martin, J.C.; Duncan, S.H.; Stewart, C.S.; Henderson, C.; Flint, H.J. Phylogenetic relationships of butyrate- producing bacteria from the human gut. Appl. Environ. Microbiol., 2000, 66(4), 1654-1661.
42. Mortensen, P.B.; Clausen, M.R.; Bonnen, H.; Hove, H.; Holtug, K. Colonic fermentation of ispaghula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects. JPEN J. Parenter. Enteral Nutr., 1992, 16(5), 433-439.
43. Bolca, S.; Possemiers, S.; Herregat, A.; Huybrechts, I.; Heyerick, A.; De Vriese, S.; Verbruggen, M.; Depypere, H.; De Keukeleire, D.; Bracke, M.; De Henauw, S.; Verstraete, W.; van de, W.T. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J. Nutr., 2007, 137(10), 2242-2246.
44. Bowey, E.; Adlercreutz, H.; Rowland, I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol., 2003, 41(5), 631-636.
45. Possemiers, S.; Bolca, S.; Eeckhaut, E.; Depypere, H.; Verstraete, W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol. Ecol., 2007, 61(2), 372-383.
46. Clavel, T.; Fallani, M.; Lepage, P.; Levenez, F.; Mathey, J.; Rochet, V.; Serezat, M.; Sutren, M.; Henderson, G.; Bennetau-Pelissero, C.; Tondu, F.; Blaut, M.; Dore, J.; Coxam, V. Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J. Nutr., 2005, 135(12), 2786-2792.
47. Kaufman, D.W.; Kelly, J.P.; Curhan, G.C.; Anderson, T.E.; Dretler, S.P.; Preminger, G.M.; Cave, D.R. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J. Am. Soc. Nephrol., 2008, 19(6), 1197-1203.
48. Wong, J.M.; de Souza, R.; Kendall, C.W.; Emam, A.; Jenkins, D.J. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol., 2006, 40(3), 235-243.
49. Elia, M.; Cummings, J.H. Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur. J. Clin. Nutr., 2007, 61(Suppl 1), S40-S74.
50. Tuohy, K.M.; Rouzaud, G.C.; Bruck, W.M.; Gibson, G.R. Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy. Curr. Pharm. Des, 2005, 11(1), 75-90.
51. Bingham, S.A. High-meat diets and cancer risk. Proc. Nutr. Soc., 1999, 58(2), 243-248.
52. van Nuenen, M.H.; Venema, K.; van der Woude, J.C.; Kuipers, E.J. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig. Dis. Sci., 2004, 49(3), 485-491.
53. Cheynier, V. Polyphenols in foods are more complex than often thought. Am. J. Clin. Nutr., 2005, 81(1 Suppl), 223S-229S.
54. Bingham, M. In Gastrointestinal Microbiology, Ouwehand, A. C.; Vaughan, E. E., Taylor & Francis Group: New York, 2006; pp. 155-168.
55. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1 Suppl), 230S-242S.
56. Rasmussen, S.E.; Frederiksen, H.; Struntze, K.K.; Poulsen, L. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol. Nutr. Food Res., 2005, 49(2), 159-174.
57. Walle, T. Absorption and metabolism of flavonoids. Free Radic. Biol. Med., 2004, 36(7), 829-837.
58. Scalbert, A.; Morand, C.; Manach, C.; Remesy, C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother., 2002, 56(6), 276-282.
59. Halliwell, B.; Rafter, J.; Jenner, A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr., 2005, 81(1 Suppl), 268S-276S.
60. Fava, F.; Lovegrove, J.A.; Gitau, R.; Jackson, K.G.; Tuohy, K.M. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr. Med. Chem., 2006, 13(25), 3005-3021.
61. Possemiers, S.; Bolca, S.; Grootaert, C.; Heyerick, A.; Decroos, K.; Dhooge, W.; De Keukeleire, D.; Rabot, S.; Verstraete, W.; van de, W.T. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr., 2006, 136(7), 1862-1867.
62. Arvola, T.; Laiho, K.; Torkkeli, S.; Mykkanen, H.; Salminen, S.; Maunula, L.; Isolauri, E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics, 1999, 104(5), e64.
63. Mendall, M.A.; Kumar, D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur. J. Gastroenterol. Hepatol., 1998, 10(1), 59-62.
64. Alverdy, J.C.; Chang, E.B. The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J Leukoc. Biol., 2008, 83(3), 461-466.
65. Flint, H.J.; Duncan, S.H.; Scott, K.P.; Louis, P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol., 2007, 9(5), 1101-1111.
66. Blaut, M.; Clavel, T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr., 2007, 137(3 Suppl 2), 751S-755S.
67. Nordling, M.M.; Glinghammar, B.; Karlsson, P.C.; de Kok, T.M.; Rafter, J.J. Effects on cell proliferation, activator protein-1 and genotoxicity by fecal water from patients with colorectal adenomas. Scand. J. Gastroenterol., 2003, 38(5), 549-555.
68. Lee, Y.K.; Hao, W.; Ho, P.S.; Nordling, M.M.; Low, C.S.; de Kok, T.M.; Rafter, J. Human fecal water modifies adhesion of intestinal bacteria to Caco-2 cells. Nutr. Cancer, 2005, 52(1), 35-42.
69. Gill, C.I.; Heavey, P.; McConville, E.; Bradbury, I.; Fassler, C.; Mueller, S.; Cresci, A.; Dore, J.; Norin, E.; Rowland, I. Effect of fecal water on an in vitro model of colonic mucosal barrier function. Nutr. Cancer, 2007, 57(1), 59-65.
70. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.J.; Brummer, R.J. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther., 2008, 27(2), 104-119.
71. Blachier, F.; Mariotti, F.; Huneau, J.F.; Tome, D. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids, 2007, 33(4), 547-562.
72. Macfarlane, G.T.; Gibson, G.R. In Physiological and Clinical Aspects of Short-Chain Fatty Acids, Cummings, J. H.; Rombeau, J. L.; Sakata, T., Cambridge University Press: Cambridge, 1995; pp. 87-105.
73. Topping, D.L.; Clifton, P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev., 2001, 81(3), 1031-1064.
74. Siavoshian, S.; Segain, J.P.; Kornprobst, M.; Bonnet, C.; Cherbut, C.; Galmiche, J.P.; Blottiere, H.M. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut, 2000, 46(4), 507-514.
75. Daly, K.; Shirazi-Beechey, S.P. Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol., 2006, 25(1), 49-62.
76. Gaudier, E.; Forestier, L.; Gouyer, V.; Huet, G.; Julien, R.; Hoebler, C. Butyrate regulation of glycosylation-related gene expression: evidence for galectin-1 upregulation in human intestinal epithelial goblet cells. Biochem. Biophys. Res. Commun., 2004, 325(3), 1044-1051.
77. Gaudier, E.; Jarry, A.; Blottiere, H.M.; de Coppet, P.; Buisine, M.P.; Aubert, J.P.; Laboisse, C.; Cherbut, C.; Hoebler, C. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am. J. Physiol Gastrointest. Liver Physiol, 2004, 287(6), G1168-G1174.
78. Segain, J.P.; Raingeard, d.l.B.; Bourreille, A.; Leray, V.; Gervois, N.; Rosales, C.; Ferrier, L.; Bonnet, C.; Blottiere, H.M.; Galmiche, J.P. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut, 2000, 47(3), 397-403.
79. Brown, A.J.; Goldsworthy, S.M.; Barnes, A.A.; Eilert, M.M.; Tcheang, L.; Daniels, D.; Muir, A.I.; Wigglesworth, M.J.; Kinghorn, I.; Fraser, N.J.; Pike, N.B.; Strum, J.C.; Steplewski, K.M.; Murdock, P.R.; Holder, J.C.; Marshall, F.H.; Szekeres, P.G.; Wilson, S.; Ignar, D.M.; Foord, S.M.; Wise, A.; Dowell, S.J. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem., 2003, 278(13), 11312-11319.
80. Le Poul, E.; Loison, C.; Struyf, S.; Springael, J.Y.; Lannoy, V.; Decobecq, M.E.; Brezillon, S.; Dupriez, V.; Vassart, G.; Van Damme, J.; Parmentier, M.; Detheux, M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem., 2003, 278(28), 25481-25489.
81. Park, J.S.; Lee, E.J.; Lee, J.C.; Kim, W.K.; Kim, H.S. Antiinflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int. Immunopharmacol., 2007, 7(1), 70-77.
82. Gibson, G.R.; McCartney, A.L.; Rastall, R.A. Prebiotics and resistance to gastrointestinal infections. Br. J. Nutr., 2005, 93(Suppl 1), S31-S34.
83. Macfarlane, S.; Macfarlane, G.T.; Cummings, J.H. Review article: prebiotics in the gastrointestinal tract. Aliment. Pharmacol. Ther., 2006, 24(5), 701-714.
84. Hinnebusch, B.F.; Meng, S.; Wu, J.T.; Archer, S.Y.; Hodin, R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr., 2002, 132(5), 1012-1017.
85. Siavoshian, S.; Blottiere, H.M.; Le Foll, E.; Kaeffer, B.; Cherbut, C.; Galmiche, J.P. Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biol. Int., 1997, 21(5), 281-287.
86. Waldecker, M.; Kautenburger, T.; Daumann, H.; Busch, C.; Schrenk, D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem., 2008, 19(9), 587-593.
87. Waldecker, M.; Kautenburger, T.; Daumann, H.; Veeriah, S.; Will, F.; Dietrich, H.; Pool-Zobel, B.L.; Schrenk, D. Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts. Nutrition, 2008, 24(4), 366-374.
88. Tedelind, S.; Westberg, F.; Kjerrulf, M.; Vidal, A. Antiinflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol., 2007, 13(20), 2826-2832.
89. Heerdt, B.G.; Chen, J.; Stewart, L.R.; Augenlicht, L.H. Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors. Cancer Res., 1994, 54(14), 3912-3915.
90. De, P., V; Cloetens, L.; Rutgeerts, P.; Verbeke, K. Influence of resistant starch alone or combined with wheat bran on gastric emptying and protein digestion in healthy volunteers. Scand. J. Gastroenterol., 2007, 42(10), 1187-1193.
91. Govers, M.J.; Gannon, N.J.; Dunshea, F.R.; Gibson, P.R.; Muir, J.G. Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs. Gut, 1999, 45(6), 840-847.
92. Lin, H.C.; Visek, W.J. Large intestinal pH and ammonia in rats: dietary fat and protein interactions. J. Nutr., 1991, 121(6), 832-843.
93. Leschelle, X.; Robert, V.; Delpal, S.; Mouille, B.; Mayeur, C.; Martel, P.; Blachier, F. Isolation of pig colonic crypts for cytotoxic assay of luminal compounds: effects of hydrogen sulfide, ammonia, and deoxycholic acid. Cell Biol. Toxicol., 2002, 18(3), 193-203.
94. Mouille, B.; Morel, E.; Robert, V.; Guihot-Joubrel, G.; Blachier, F. Metabolic capacity for L-citrulline synthesis from ammonia in rat isolated colonocytes. Biochim. Biophys. Acta, 1999, 1427(3), 401-407.
95. Ichikawa, H.; Sakata, T. Stimulation of epithelial cell proliferation of isolated distal colon of rats by continuous colonic infusion of ammonia or short-chain fatty acids is nonadditive. J. Nutr., 1998, 128(5), 843-847.
96. Hulin, S.J.; Singh, S.; Chapman, M.A.; Allan, A.; Langman, M.J.; Eggo, M.C. Sulphide-induced energy deficiency in colonic cells is prevented by glucose but not by butyrate. Aliment. Pharmacol. Ther., 2002, 16(2), 325-331.
97. Roediger, W.E.; Duncan, A.; Kapaniris, O.; Millard, S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin. Sci. (Lond), 1993, 85(5), 623-627.
98. Loser, C.; Eisel, A.; Harms, D.; Folsch, U.R. Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut, 1999, 44(1), 12-16.
99. Larque, E.; Sabater-Molina, M.; Zamora, S. Biological significance of dietary polyamines. Nutrition, 2007, 23(1), 87-95.
100. De Smet, R.; Van Kaer, J.; Van Vlem, B.; De Cubber, A.; Brunet, P.; Lameire, N.; Vanholder, R. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin. Chem., 2003, 49(3), 470-478.
101. Hugues, R.; Magee, E.A.M.; Bingham, S. Protein degradation in the large intestine: relevance to colorectal cancer. Curr Issues Intest. Microbiol., 2000, 1 51-58.
102. Schepers, E.; Meert, N.; Glorieux, G.; Goeman, J.; Van der, E.J.; Vanholder, R. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial. Transplant., 2007, 22(2), 592-596.
103. Atkinson, C.; Frankenfeld, C.L.; Lampe, J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. (Maywood.), 2005, 230(3), 155-170.
104. Jackman, K.A.; Woodman, O.L.; Sobey, C.G. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr. Med. Chem., 2007, 14(26), 2824-2830.
105. Vafeiadou, K.; Hall, W.L.; Williams, C.M. Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women. Proc. Nutr. Soc., 2006, 65(1), 106-115.
106. Vatanparast, H.; Chilibeck, P.D. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? Nutr. Rev., 2007, 65(6 Pt 1), 294-299.
107. Yuan, J.P.; Wang, J.H.; Liu, X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora - implications for health. Mol. Nutr. Food Res., 2007, 51(7), 765-781.
108. Arora, A.; Nair, M.G.; Strasburg, G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys., 1998, 356(2), 133-141.
109. Hwang, J.; Wang, J.; Morazzoni, P.; Hodis, H.N.; Sevanian, A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic. Biol. Med., 2003, 34(10), 1271-1282.
110. Mitchell, J.H.; Gardner, P.T.; McPhail, D.B.; Morrice, P.C.; Collins, A.R.; Duthie, G.G. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys., 1998, 360(1), 142-148.
111. Rufer, C.E.; Kulling, S.E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem., 2006, 54(8), 2926-2931.
112. Hall, W.L.; Vafeiadou, K.; Hallund, J.; Bugel, S.; Koebnick, C.; Reimann, M.; Ferrari, M.; Branca, F.; Talbot, D.; Dadd, T.; Nilsson, M.; Dahlman-Wright, K.; Gustafsson, J.A.; Minihane, A.M.; Williams, C.M. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am. J. Clin. Nutr., 2005, 82(6), 1260-1268.
113. Ryan-Borchers, T.A.; Park, J.S.; Chew, B.P.; McGuire, M.K.; Fournier, L.R.; Beerman, K.A. Soy isoflavones modulate immune function in healthy postmenopausal women. Am. J. Clin. Nutr., 2006, 83(5), 1118-1125.
114. Cerda, B.; Espin, J.C.; Parra, S.; Martinez, P.; Tomas-Barberan, F.A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur. J. Nutr., 2004, 43(4), 205-220.
115. Ito, H.; Iguchi, A.; Hatano, T. Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats. J. Agric. Food Chem., 2008, 56(2), 393-400.
116. Unno, T.; Tamemoto, K.; Yayabe, F.; Kakuda, T. Urinary excretion of 5-(3′,4′-dihydroxyphenyl)-gamma-valerolactone, a ring-fission metabolite of (-)-epicatechin, in rats and its in vitro antioxidant activity. J. Agric. Food Chem., 2003, 51(23), 6893-6898.
117. Merfort, I.; Heilmann, J.; Weiss, M.; Pietta, P.; Gardana, C. Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemiluminescence in human PMNs. Planta Med., 1996, 62(4), 289-292.
118. Karlsson, P.C.; Huss, U.; Jenner, A.; Halliwell, B.; Bohlin, L.; Rafter, J.J. Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J. Nutr., 2005, 135(10), 2343-2349.
119. Ruiz, P.A.; Braune, A.; Holzlwimmer, G.; Quintanilla-Fend, L.; Haller, D. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr., 2007, 137(5), 1208-1215.
120. Lambert, J.D.; Lee, M.J.; Diamond, L.; Ju, J.; Hong, J.; Bose, M.; Newmark, H.L.; Yang, C.S. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos., 2006, 34(1), 8-11.
121. Russell, W.R.; Labat, A.; Scobbie, L.; Duncan, S.H. Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol. Nutr. Food Res., 2007, 51(6), 726-731.
122. Gao, K.; Xu, A.; Krul, C.; Venema, K.; Liu, Y.; Niu, Y.; Lu, J.; Bensoussan, L.; Seeram, N.P.; Heber, D.; Henning, S.M. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr., 2006, 136(1), 52-57.
123. Kim, D.H.; Kim, S.Y.; Park, S.Y.; Han, M.J. Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities. Biol. Pharm. Bull., 1999, 22(7), 749-751.
124. Lambert, J.D.; Rice, J.E.; Hong, J.; Hou, Z.; Yang, C.S. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg. Med. Chem. Lett., 2005, 15(4), 873-876.
125. Lambert, J.D.; Sang, S.; Hong, J.; Kwon, S.J.; Lee, M.J.; Ho, C.T.; Yang, C.S. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos., 2006, 34(12), 2111-2116.
126. Lambert, J.D.; Sang, S.; Yang, C.S. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm., 2007, 4(6), 819-825.
127. Lea, M.A.; Sura, M.; Desbordes, C. Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists. Anticancer Res., 2004, 24(5A), 2765-2771.
128. Marks, P.A.; Richon, V.M.; Kelly, W.K.; Chiao, J.H.; Miller, T. Histone deacetylase inhibitors: development as cancer therapy. Novartis. Found. Symp., 2004, 259 269-281.
129. Jenner, A.M.; Rafter, J.; Halliwell, B. Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic. Biol. Med., 2005, 38(6), 763-772.
130. Griffin, J.L. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos. Trans. R. Soc. Lond. B Biol. Sci., 2006, 361(1465), 147-161.
131. Mashego, M.R.; Rumbold, K.; De Mey, M.; Vandamme, E.; Soetaert, W.; Heijnen, J.J. Microbial metabolomics: past, present and future methodologies. Biotechnol. Lett., 2007, 29(1), 1-16.
132. Hoverstad, T.; Fausa, O.; Bjorneklett, A.; Bohmer, T. Short-chain fatty acids in the normal human feces. Scand. J. Gastroenterol., 1984, 19(3), 375-381.
133. Meijer-Severs, G.J.; van Santen, E. Short-chain fatty acid and organic acid concentrations in feces of 10 human volunteers and their correlation with anaerobe cultural over a 15-month period. Scand. J. Gastroenterol., 1989, 24(10), 1276-1280.
134. Puupponen-Pimia, R.; Aura, A.-M.; Oksman-Caldentey, K.-M.; Myllarinen, P.; Saarela, M.; Mattila-Sandholm, T.; Poutanen, K. Development of functional ingredients for gut health. Trends Food Sci. Technol., 2002, 13 3-11.
135. Siigur, U.; Ormisson, A.; Tamm, A. Faecal short-chain fatty acids in breast-fed and bottle-fed infants. Acta Paediatr., 1993, 82(6-7), 536-538.
136. Zhao, G.; Nyman, M.; Jonsson, J.A. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed. Chromatogr., 2006, 20(8), 674-682.
137. Parrett, A.M.; Edwards, C.A. In vitro fermentation of carbohydrate by breast fed and formula fed infants. Arch. Dis. Child, 1997, 76(3), 249-253.
138. Pylkas, A.M.; Juneja, L.R.; Slavin, J.L. Comparison of different fibers for in vitro production of short chain fatty acids by intestinal microflora. J. Med. Food, 2005, 8(1), 113-116.
139. Jacobs, D.M.; Deltimple, N.; van Velzen, E.; van Dorsten, F.A.; Bingham, M.; Vaughan, E.E.; van Duynhoven, J. (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed., 2008, 21(6), 615-626.
140. Saric, J.; Wang, Y.; Li, J.; Coen, M.; Utzinger, J.; Marchesi, J.R.; Keiser, J.; Veselkov, K.; Lindon, J.C.; Nicholson, J.K.; Holmes, E. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res., 2008, 7(1), 352-360.
141. Pang, X.; Hua, X.; Yang, Q.; Ding, D.; Che, C.; Cui, L.; Jia, W.; Bucheli, P.; Zhao, L. Inter-species transplantation of gut microbiota from human to pigs. ISME. J., 2007, 1(2), 156-162.
142. Marchesi, J.R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I.D.; Wang, Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome. Res., 2007, 6(2), 546-551.
143. Scanlan, P.D.; Shanahan, F.; Clune, Y.; Collins, J.K.; O'Sullivan, G.C.; O'Riordan, M.; Holmes, E.; Wang, Y.; Marchesi, J.R. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol., 2008, 10(3), 789-798.
144. Nyman, M. Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br. J. Nutr., 2002, 87(2 Suppl), S163-S168.
145. Morita, T.; Kasaoka, S.; Kiriyama, S. Physiological functions of resistant proteins: proteins and peptides regulating large bowel fermentation of indigestible polysaccharide. J. AOAC Int., 2004, 87(3), 792-796.
146. Lamers, R.J.; Wessels, E.C.; van de Sandt, J.J.; Venema, K.; Schaafsma, G.; van der, G.J.; van Nesselrooij, J.H. A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprinting. J. Nutr., 2003, 133(10), 3080-3084.
147. van de Wiele, T.; Boon, N.; Possemiers, S.; Jacobs, H.; Verstraete, W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J. Appl. Microbiol., 2007, 102(2), 452-460.
148. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.; Moore, K.P.; Rice-Evans, C.A. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med., 2004, 36(2), 212-225.
149. Tzounis, X.; Vulevic, J.; Kuhnle, G.G.; George, T.; Leonczak, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr., 2008, 99(4), 782-792.
150. van de Wiele, T.; Boon, N.; Possemiers, S.; Jacobs, H.; Verstraete, W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol., 2004, 51(1), 143-153.
151. Macfarlane, G.T.; Macfarlane, S.; Gibson, G.R. Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon. Microb. Ecol., 1998, 35(2), 180-187.
152. Minekus, M.; Smeets-Peeters, M.; Bernalier, A.; Marol-Bonnin, S.; Havenaar, R.; Marteau, P.; Alric, M.; Fonty, G.; Huis, i., V A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl. Microbiol. Biotechnol., 1999, 53(1), 108-114.
153. Williams, R.E.; Eyton-Jones, H.W.; Farnworth, M.J.; Gallagher, R.; Provan, W.M. Effect of intestinal microflora on the urinary metabolic profile of rats: a (1)H-nuclear magnetic resonance spectroscopy study. Xenobiotica, 2002, 32(9), 783-794.
154. Gavaghan, C.L.; Nicholson, J.K.; Connor, S.C.; Wilson, I.D.; Wright, B.; Holmes, E. Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague-Dawley rats. Anal. Biochem., 2001, 291(2), 245-252.
155. Nicholls, A.W.; Mortishire-Smith, R.J.; Nicholson, J.K. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol., 2003, 16(11), 1395-1404.
156. Li, H.; Ni, Y.; Su, M.; Qiu, Y.; Zhou, M.; Qiu, M.; Zhao, A.; Zhao, L.; Jia, W. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. J. Proteome Res., 2007, 6(4), 1364-1370.
157. Wang, Y.; Utzinger, J.; Xiao, S.H.; Xue, J.; Nicholson, J.K.; Tanner, M.; Singer, B.H.; Holmes, E. System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol. Biochem. Parasitol., 2006, 146(1), 1-9.
158. Wang, Y.; Holmes, E.; Nicholson, J.K.; Cloarec, O.; Chollet, J.; Tanner, M.; Singer, B.H.; Utzinger, J. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. USA, 2004, 101(34), 12676-12681.
159. Gao, X.X.; Ge, H.M.; Zheng, W.F.; Tan, R.X. NMR-based metabonomics for detection of Helicobacter pylori infection in gerbils: which is more descriptive. Helicobacter, 2008, 13(2), 103-111.
160. Coen, M.; O'Sullivan, M.; Bubb, W.A.; Kuchel, P.W.; Sorrell, T. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin. Infect. Dis., 2005, 41(11), 1582-1590.
161. Nath, S.K. Tropical sprue. Curr. Gastroenterol. Rep., 2005, 7(5), 343-349.
162. Stella, C.; Beckwith-Hall, B.; Cloarec, O.; Holmes, E.; Lindon, J.C.; Powell, J.; van der, O.F.; Bingham, S.; Cross, A.J.; Nicholson, J.K. Susceptibility of human metabolic phenotypes to dietary modulation. J. Proteome Res., 2006, 5(10), 2780-2788.
163. Martin, F.P.; Wang, Y.; Sprenger, N.; Yap, I.K.; Lundstedt, T.; Lek, P.; Rezzi, S.; Ramadan, Z.; van Bladeren, P.; Fay, L.B.; Kochhar, S.; Lindon, J.C.; Holmes, E.; Nicholson, J.K. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol., 2008, 4 157.
164. Dumas, M.E.; Barton, R.H.; Toye, A.; Cloarec, O.; Blancher, C.; Rothwell, A.; Fearnside, J.; Tatoud, R.; Blanc, V.; Lindon, J.C.; Mitchell, S.C.; Holmes, E.; McCarthy, M.I.; Scott, J.; Gauguier, D.; Nicholson, J.K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA, 2006, 103(33), 12511-12516.
165. Bertram, H.C.; Bach Knudsen, K.E.; Serena, A.; Malmendal, A.; Nielsen, N.C.; Frette, X.C.; Andersen, H.J. NMR-based metabonomic studies reveal changes in the biochemical profile of plasma and urine from pigs fed high-fibre rye bread. Br. J. Nutr., 2006, 95(5), 955-962.
166. Walsh, M.C.; Brennan, L.; Pujos-Guillot, E.; Sebedio, J.L.; Scalbert, A.; Fagan, A.; Higgins, D.G.; Gibney, M.J. Influence of acute phytochemical intake on human urinary metabolomic profiles. Am. J. Clin. Nutr., 2007, 86(6), 1687-1693.
167. Phipps, A.N.; Stewart, J.; Wright, B.; Wilson, I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica, 1998, 28(5), 527-537.
168. Wang, Y.; Tang, H.; Nicholson, J.K.; Hylands, P.J.; Sampson, J.; Holmes, E. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem., 2005, 53(2), 191-196.
169. Daykin, C.A.; Van Duynhoven, J.P.; Groenewegen, A.; Dachtler, M.; Van Amelsvoort, J.M.; Mulder, T.P. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J. Agric. Food Chem., 2005, 53(5), 1428-1434.
170. van Dorsten, F.A.; Daykin, C.A.; Mulder, T.P.; Van Duynhoven, J.P. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J. Agric. Food Chem., 2006, 54(18), 6929-6938.
171. Solanky, K.S.; Bailey, N.J.; Beckwith-Hall, B.M.; Bingham, S.; Davis, A.; Holmes, E.; Nicholson, J.K.; Cassidy, A. Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans. J. Nutr. Biochem., 2005, 16(4), 236-244.
172. Wang, X.; Su, M.; Qiu, Y.; Ni, Y.; Zhao, T.; Zhou, M.; Zhao, A.; Yang, S.; Zhao, L.; Jia, W. Metabolic regulatory network alterations in response to acute cold stress and ginsenoside intervention. J. Proteome Res., 2007, 6(9), 3449-3455.
173. Grun, C.H.; van Dorsten, F.A.; Jacobs, D.M.; Le Belleguic, M.; van Velzen, E.J.; Bingham, M.O.; Janssen, H.G.; Van Duynhoven, J.P. GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2008, 871(2), 212-219.
174. Gonthier, M.P.; Cheynier, V.; Donovan, J.L.; Manach, C.; Morand, C.; Mila, I.; Lapierre, C.; Remesy, C.; Scalbert, A. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr., 2003, 133(2), 461-467.
175. Mennen, L.I.; Sapinho, D.; Ito, H.; Galan, P.; Hercberg, S.; Scalbert, A. Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake. Eur. J. Clin. Nutr., 2008, 62(4), 519-525.
176. Chen, C.; Shah, Y.M.; Morimura, K.; Krausz, K.W.; Miyazaki, M.; Richardson, T.A.; Morgan, E.T.; Ntambi, J.M.; Idle, J.R.; Gonzalez, F.J. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab., 2008, 7(2), 135-147.
177. Watson, A.D. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J. Lipid Res., 2006, 47(10), 2101-2111.
178. Mohajer, B.; Ma, T.Y. Eicosanoids and the small intestine. Prostaglandins Other Lipid Mediat., 2000, 61(3-4), 125-143.
179. Boren, J.; Lee, W.N.; Bassilian, S.; Centelles, J.J.; Lim, S.; Ahmed, S.; Boros, L.G.; Cascante, M. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J. Biol. Chem., 2003, 278(31), 28395-28402.
180. Jorgensen, J.; Mortensen, P.B. Utilization of short-chain fatty acids by colonic mucosal tissue strips. A new method of assessing colonic mucosal metabolism. Scand. J. Gastroenterol., 2000, 35(6), 659-666.
181. Pouteau, E.; Frenais, R.; Dumon, H.; Noah, L.; Martin, L.; Nguyen, P. Colonic fermentation of inulin increases whole-body acetate turnover in dogs. J. Nutr., 2005, 135(12), 2845-2851.
182. Metges, C.C. Contribution of microbial amino acids to amino acid homeostasis of the host. J. Nutr., 2000, 130(7), 1857S-1864S.
183. Egert, M.; de Graaf, A.A.; Smidt, H.; de Vos, W.M.; Venema, K. Beyond diversity: functional microbiomics of the human colon. Trends Microbiol., 2006, 14(2), 86-91.
184. Egert, M.; de Graaf, A.A.; Maathuis, A.; de Waard, P.; Plugge, C.M.; Smidt, H.; Deutz, N.E.; Dijkema, C.; de Vos, W.M.; Venema, K. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol. Ecol., 2007, 60(1), 126-135.
185. Louis, P.; Scott, K.P.; Duncan, S.H.; Flint, H.J. Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol., 2007, 102(5), 1197-1208.
186. Rogers, A.H.; Chen, J.; Zilm, P.S.; Gully, N.J. The behaviour of Fusobacterium nucleatum chemostat-grown in glucose- and amino acid-based chemically defined media. Anaerobe, 1998, 4(2), 111-116.
187. Thompson, J.; Nguyen, N.Y.; Robrish, S.A. Sucrose fermentation by Fusobacterium mortiferum ATCC 25557: transport, catabolism, and products. J. Bacteriol., 1992, 174(10), 3227-3235.
188. Zoetendal, E.G.; Plugge, C.M.; Akkermans, A.D.; de Vos, W.M. Victivallis vadensis gen. nov., sp. nov., a sugar-fermenting anaerobe from human faeces. Int. J. Syst. Evol. Microbiol., 2003, 53(Pt 1), 211-215.